Risk Assessment Report – 22 june 2020
Risk Assessment Report – 22 june 2020
Rapid Risk Assessment
June 22, 2020
Risk Assessment Report – 22 june 2020
Time Period Covered June 22, 2020 - June 22, 2020
- Worldwide, there have been more than 8.9 million cases, and over 460,000 deaths attributed to COVID-19. The WHO has warned that the global spread of the virus is accelerating after a daily high of more than 150,000 cases was reported last week.
- World Health Organization (WHO) has published ‘Criteria for releasing COVID19 patients from isolation’ which provides an update to previous guidance. The updated criteria reflect recent findings that patients whose symptoms have resolved may still test positive for the COVID-19 virus for many weeks. Despite this positive test result, these patients are not likely to be infectious and therefore are unlikely to be able to transmit the virus to another person. WHO also published an Emergency Global Supply Chain System (COVID-19) catalogue. This catalogue lists all medical devices, including personal protective equipment, medical equipment, medical consumables, single use devices, laboratory and test-related devices that may be requested through the COVID-19 Supply Portal.
- The WHO Regional Director for Europe, Dr Hans Henri P. Kluge, shared that the European Region accounts for 31% of COVID-19 cases and 43% of COVID-19 deaths globally. Dr Kluge highlighted that several countries continue to face increasing disease incidence and that “Preparing for the autumn is a priority now at the WHO Regional Office for Europe” (WHO Report 153).
- Chinese researchers have started a second phase human trial of a possible coronavirus vaccine, the Institute of Medical Biology at Chinese Academy of Medical Sciences (IMBCAMS) said on Sunday (June 21). IMBCAMS began on Saturday a phase-2 human test for its experimental shot, which is among six possible vaccines Chinese scientists are testing in humans, following an ongoing phase-1 study that has recruited about 200 participants since May. The phase-2 trial will determine the shot's dose and continue to evaluate whether the potential vaccine can safely trigger immune responses in healthy people.
- Indonesia’s COVID-19 task force inaugurates Lamongan infectious diseases center last June 18. The new infectious diseases facility, which covers 6,180 square meters, is to admit and treat COVID-19 patients from Lamongan regency as well as other regions in East Java, the new epicenter of the Indonesian outbreak. The Health Ministry announced 862 new confirmed COVID-19 cases as of June 21, bringing the total number of infections nationwide to 45,891.
- One of Philippines’ representative recommended the pooled sampling strategy to increase testing capacity using existing equipment and expand it to the widest possible coverage. The pooled testing method, which puts swab samples of multiple individuals into a single polymerase chain reaction (PCR) test, would only require 100,000 kits to cover and test one million people for COVID-19. If a positive result comes from a single batch of pooled tests, further individual assessments will be made. The test is designed to be sensitive enough to come up positive when at least one sample in the batch is positive. On the other hand, if the swab test of multiple individuals comes back negative, then individual tests need not be performed
Risk Assessment Report – 22 june 2020